CN105331625A - 一种纳米羟基磷灰石基因载体及其制备方法 - Google Patents
一种纳米羟基磷灰石基因载体及其制备方法 Download PDFInfo
- Publication number
- CN105331625A CN105331625A CN201510799147.6A CN201510799147A CN105331625A CN 105331625 A CN105331625 A CN 105331625A CN 201510799147 A CN201510799147 A CN 201510799147A CN 105331625 A CN105331625 A CN 105331625A
- Authority
- CN
- China
- Prior art keywords
- polyethylene glycol
- hap
- methoxy polyethylene
- polymine
- mono methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 107
- 238000002360 preparation method Methods 0.000 title abstract description 21
- 108090000623 proteins and genes Proteins 0.000 title abstract description 20
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 127
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 87
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 105
- 239000000243 solution Substances 0.000 claims description 94
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 85
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 239000008367 deionised water Substances 0.000 claims description 36
- 229910021641 deionized water Inorganic materials 0.000 claims description 36
- 238000002156 mixing Methods 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 238000001556 precipitation Methods 0.000 claims description 16
- 239000002798 polar solvent Substances 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 2
- 238000001890 transfection Methods 0.000 abstract description 61
- 230000004048 modification Effects 0.000 abstract description 10
- 238000012986 modification Methods 0.000 abstract description 10
- 231100000419 toxicity Toxicity 0.000 abstract description 10
- 230000001988 toxicity Effects 0.000 abstract description 10
- 238000012637 gene transfection Methods 0.000 abstract description 8
- 238000000338 in vitro Methods 0.000 abstract description 8
- 239000002105 nanoparticle Substances 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 5
- 101150026524 hap gene Proteins 0.000 abstract description 2
- 230000003612 virological effect Effects 0.000 abstract 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 69
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 64
- 229920002873 Polyethylenimine Polymers 0.000 description 52
- 210000004027 cell Anatomy 0.000 description 50
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 32
- 239000007788 liquid Substances 0.000 description 31
- 239000013612 plasmid Substances 0.000 description 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- 229960001701 chloroform Drugs 0.000 description 24
- 239000002539 nanocarrier Substances 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 20
- 239000000203 mixture Substances 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000013078 crystal Substances 0.000 description 15
- 239000002502 liposome Substances 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 14
- 238000012549 training Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 229920001427 mPEG Polymers 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 241000700605 Viruses Species 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 11
- 230000001413 cellular effect Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 9
- 238000013016 damping Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 239000002775 capsule Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 229920006317 cationic polymer Polymers 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 239000006059 cover glass Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 5
- 210000003477 cochlea Anatomy 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 235000011194 food seasoning agent Nutrition 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 238000001415 gene therapy Methods 0.000 description 4
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 229920000909 polytetrahydrofuran Polymers 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 210000001323 spiral ganglion Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- 102000004230 Neurotrophin 3 Human genes 0.000 description 3
- 108090000742 Neurotrophin 3 Proteins 0.000 description 3
- 108010019160 Pancreatin Proteins 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 238000002242 deionisation method Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 3
- 229960004756 ethanol Drugs 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 229940032018 neurotrophin 3 Drugs 0.000 description 3
- 229940055695 pancreatin Drugs 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000003151 transfection method Methods 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000000721 basilar membrane Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940096422 collagen type i Drugs 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000006481 glucose medium Substances 0.000 description 2
- 229910004700 hPO4 Inorganic materials 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000962 poly(amidoamine) Polymers 0.000 description 2
- 229920001601 polyetherimide Polymers 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 101100004286 Caenorhabditis elegans best-5 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001248531 Euchloe <genus> Species 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012580 N-2 Supplement Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101150057615 Syn gene Proteins 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 230000005260 alpha ray Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005745 host immune response Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 231100000916 relative toxicity Toxicity 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000002205 spiral ligament of cochlea Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000645 stria vascularis Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000003582 temporal bone Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510799147.6A CN105331625B (zh) | 2015-11-18 | 2015-11-18 | 一种纳米羟基磷灰石基因载体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510799147.6A CN105331625B (zh) | 2015-11-18 | 2015-11-18 | 一种纳米羟基磷灰石基因载体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105331625A true CN105331625A (zh) | 2016-02-17 |
CN105331625B CN105331625B (zh) | 2019-02-26 |
Family
ID=55282391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510799147.6A Active CN105331625B (zh) | 2015-11-18 | 2015-11-18 | 一种纳米羟基磷灰石基因载体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105331625B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101928458A (zh) * | 2010-07-07 | 2010-12-29 | 四川大学 | 改性聚乙烯亚胺构建的多功能纳米复合粒子的制备方法 |
CN104288784A (zh) * | 2014-10-24 | 2015-01-21 | 浙江理工大学 | 纳米羟基磷灰石-基因-药物复合物及制备方法和应用 |
-
2015
- 2015-11-18 CN CN201510799147.6A patent/CN105331625B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101928458A (zh) * | 2010-07-07 | 2010-12-29 | 四川大学 | 改性聚乙烯亚胺构建的多功能纳米复合粒子的制备方法 |
CN104288784A (zh) * | 2014-10-24 | 2015-01-21 | 浙江理工大学 | 纳米羟基磷灰石-基因-药物复合物及制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
向建南等: "一种新颖的阳离子非病毒基因载体Chitosan-g-PEI-g-PEG-OH的性能研究", 《湖南大学学报(自然科学版)》 * |
吴正茂等: "纳米羟基磷灰石表面修饰及其转染细胞的研究", 《现代生物医学进展》 * |
Also Published As
Publication number | Publication date |
---|---|
CN105331625B (zh) | 2019-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110448696B (zh) | 基于盐藻外泌体靶向药物递送载体的制备方法与应用 | |
CN109837306A (zh) | 包载miRNA-204-5p的外泌体及其制备方法和应用 | |
CN105362251B (zh) | DOTAP-mPEG-PLA纳米粒及其纳米粒溶液、载药复合物和制备方法和应用 | |
CN101831000A (zh) | 乙酰普鲁兰多糖叶酸偶联物的纯化及其纳米粒子的制备方法 | |
CN108329404B (zh) | 一种ir-780碘化物-壳聚糖硬脂酸嫁接物及制备与应用 | |
CN111544598B (zh) | 负载Survivin双抑制剂的铁蛋白纳米颗粒及其制备方法和应用 | |
CN114479090B (zh) | 一种氟化聚乙二醇-聚乙烯亚胺及其制备方法和应用 | |
CN109674764B (zh) | 一种抗肿瘤磁性载药杂化纳米胶囊及其制备方法 | |
CN104974343B (zh) | 改性聚乙烯亚胺及其在制备基因转染载体试剂中的应用 | |
CN104099372A (zh) | 一种阳离子化丝素蛋白/基因复合物、制备方法及其应用 | |
CN107007550B (zh) | 一种氧化还原响应性两亲性共聚物及其制备方法和应用 | |
CN107530279A (zh) | 含聚(l‑精氨酸)链段的嵌段共聚物与聚阴离子性聚合物的聚离子复合物 | |
CN109045304A (zh) | 一种携带Polymerase I抑制剂的核仁靶向纳米载体及其制备方法和应用 | |
CN107837400B (zh) | 一种新型纳米基因载体及其制备方法 | |
CN106086079A (zh) | 多重靶向修饰的载基因复合物及制备方法及应用 | |
CN105331625A (zh) | 一种纳米羟基磷灰石基因载体及其制备方法 | |
CN105861560A (zh) | 低毒介孔二氧化硅基因纳米载体的制备方法及其应用 | |
CN109674741B (zh) | 药物载体及其制备方法 | |
CN108997575A (zh) | 聚乙二醇-b-聚酪氨酸-硫辛酸共聚物、聚多肽胶束及其制备方法与应用 | |
CN110384680A (zh) | 一种温度/pH响应性双载药复合纳米粒子及其制备方法和用途 | |
CN108531514B (zh) | 内源性超支化聚精胺阳离子基因载体及其制备方法与应用 | |
CN107778377B (zh) | 四碘甲腺乙酸修饰的壳寡糖硬脂酸嫁接物及制备和应用 | |
CN108721636B (zh) | 联硒键连接的具有双重响应性的药物递送材料及其制备方法和应用 | |
CN109276712A (zh) | 纳米合成酶在细胞中促进高分子透明质酸合成的应用 | |
CN102462846B (zh) | 一种氯代毒素修饰的脑胶质瘤靶向基因递释复合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200616 Address after: 410001 No.87 Xiangya Road, Kaifu District, Changsha City, Hunan Province Patentee after: XIANGYA HOSPITAL OF CENTRAL SOUTH University Address before: Yuelu District City, Hunan province 410083 Changsha Lushan Road No. 932 Patentee before: CENTRAL SOUTH University |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Fengjun Inventor after: Sun Hong Inventor after: Wu Xuewen Inventor after: Qiang Qingfen Inventor after: Xu Zhenhang Inventor after: Liu Mingyu Inventor before: Sun Hong Inventor before: Wang Fengjun Inventor before: Wu Xuewen Inventor before: Qiang Qingfen Inventor before: Xu Zhenhang Inventor before: Liu Mingyu |
|
CB03 | Change of inventor or designer information |